Format
Items per page
Sort by

Send to:

Choose Destination

Links from PubMed

Items: 1 to 20 of 161

1.

Tristetraprolin down-regulates interleukin-8 and vascular endothelial growth factor in malignant glioma cells.

Suswam E, Li Y, Zhang X, Gillespie GY, Li X, Shacka JJ, Lu L, Zheng L, King PH.

Cancer Res. 2008 Feb 1;68(3):674-82. doi: 10.1158/0008-5472.CAN-07-2751.

2.

Tumor necrosis factor alpha induces angiogenic factor up-regulation in malignant glioma cells: a role for RNA stabilization and HuR.

Nabors LB, Suswam E, Huang Y, Yang X, Johnson MJ, King PH.

Cancer Res. 2003 Jul 15;63(14):4181-7.

3.

Mitogen-activated protein kinase-activated protein kinase 2 regulates tumor necrosis factor mRNA stability and translation mainly by altering tristetraprolin expression, stability, and binding to adenine/uridine-rich element.

Hitti E, Iakovleva T, Brook M, Deppenmeier S, Gruber AD, Radzioch D, Clark AR, Blackshear PJ, Kotlyarov A, Gaestel M.

Mol Cell Biol. 2006 Mar;26(6):2399-407.

4.

Heparanase induces vascular endothelial growth factor expression: correlation with p38 phosphorylation levels and Src activation.

Zetser A, Bashenko Y, Edovitsky E, Levy-Adam F, Vlodavsky I, Ilan N.

Cancer Res. 2006 Feb 1;66(3):1455-63.

5.

Mutant tristetraprolin: a potent inhibitor of malignant glioma cell growth.

Suswam EA, Shacka JJ, Walker K, Lu L, Li X, Si Y, Zhang X, Zheng L, Nabors LB, Cao H, King PH.

J Neurooncol. 2013 Jun;113(2):195-205. doi: 10.1007/s11060-013-1112-8. Epub 2013 Mar 25.

7.

Tristetraprolin inhibits Ras-dependent tumor vascularization by inducing vascular endothelial growth factor mRNA degradation.

Essafi-Benkhadir K, Onesto C, Stebe E, Moroni C, Pagès G.

Mol Biol Cell. 2007 Nov;18(11):4648-58. Epub 2007 Sep 12.

8.

[Nordy inhibits cell proliferation and angiogenic factor production of malignant human glioma cells mediated by formylpeptide receptor].

Yao XH, Ping YF, Bian XW, Chen JH, Wang QL, Jiang XF.

Zhonghua Yi Xue Za Zhi. 2007 Feb 13;87(7):479-84. Chinese.

PMID:
17459229
9.

Constitutive ERK activity induces downregulation of tristetraprolin, a major protein controlling interleukin8/CXCL8 mRNA stability in melanoma cells.

Bourcier C, Griseri P, Grépin R, Bertolotto C, Mazure N, Pagès G.

Am J Physiol Cell Physiol. 2011 Sep;301(3):C609-18. doi: 10.1152/ajpcell.00506.2010. Epub 2011 May 18.

10.

Decrease of endogenous vascular endothelial growth factor may not affect glioma cell proliferation and invasion.

Hong X, Jiang F, Kalkanis SN, Zhang ZG, Zhang X, Zheng X, Mikkelsen T, Jiang H, Chopp M.

J Exp Ther Oncol. 2007;6(3):219-29.

PMID:
17552362
11.

The stability of tristetraprolin mRNA is regulated by mitogen-activated protein kinase p38 and by tristetraprolin itself.

Tchen CR, Brook M, Saklatvala J, Clark AR.

J Biol Chem. 2004 Jul 30;279(31):32393-400. Epub 2004 Jun 7.

12.

Tristetraprolin regulates expression of VEGF and tumorigenesis in human colon cancer.

Lee HH, Son YJ, Lee WH, Park YW, Chae SW, Cho WJ, Kim YM, Choi HJ, Choi DH, Jung SW, Min YJ, Park SE, Lee BJ, Cha HJ, Park JW.

Int J Cancer. 2010 Apr 15;126(8):1817-27. doi: 10.1002/ijc.24847.

13.

Tristetraprolin (TTP)-14-3-3 complex formation protects TTP from dephosphorylation by protein phosphatase 2a and stabilizes tumor necrosis factor-alpha mRNA.

Sun L, Stoecklin G, Van Way S, Hinkovska-Galcheva V, Guo RF, Anderson P, Shanley TP.

J Biol Chem. 2007 Feb 9;282(6):3766-77. Epub 2006 Dec 14.

14.

Regulation of tristetraprolin expression by interleukin-1 beta and dexamethasone in human pulmonary epithelial cells: roles for nuclear factor-kappa B and p38 mitogen-activated protein kinase.

King EM, Kaur M, Gong W, Rider CF, Holden NS, Newton R.

J Pharmacol Exp Ther. 2009 Aug;330(2):575-85. doi: 10.1124/jpet.109.151423. Epub 2009 May 12.

15.

Differential regulation of ARE-mediated TNFalpha and IL-1beta mRNA stability by lipopolysaccharide in RAW264.7 cells.

Chen YL, Huang YL, Lin NY, Chen HC, Chiu WC, Chang CJ.

Biochem Biophys Res Commun. 2006 Jul 21;346(1):160-8. Epub 2006 May 24.

PMID:
16759646
16.

Destabilization of vascular endothelial growth factor mRNA by the zinc-finger protein TIS11b.

Ciais D, Cherradi N, Bailly S, Grenier E, Berra E, Pouyssegur J, Lamarre J, Feige JJ.

Oncogene. 2004 Nov 11;23(53):8673-80.

PMID:
15467755
17.
18.

The role of thrombin in the neo-vascularization of malignant gliomas: an intrinsic modulator for the up-regulation of vascular endothelial growth factor.

Yamahata H, Takeshima H, Kuratsu J, Sarker KP, Tanioka K, Wakimaru N, Nakata M, Kitajima I, Maruyama I.

Int J Oncol. 2002 May;20(5):921-8.

PMID:
11956584
19.

Inhibition of protein kinase Cdelta reduces tristetraprolin expression by destabilizing its mRNA in activated macrophages.

Leppänen T, Jalonen U, Korhonen R, Tuominen RK, Moilanen E.

Eur J Pharmacol. 2010 Feb 25;628(1-3):220-5. doi: 10.1016/j.ejphar.2009.11.014. Epub 2009 Nov 17.

PMID:
19925787
20.

Tristetraprolin regulates CXCL1 (KC) mRNA stability.

Datta S, Biswas R, Novotny M, Pavicic PG Jr, Herjan T, Mandal P, Hamilton TA.

J Immunol. 2008 Feb 15;180(4):2545-52.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk